Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted

Yi Cheng Lin, Li Nien Chien, Chun Yao Huang

研究成果: 雜誌貢獻 › 快報 › 同行評審

原文	英語
頁（從 - 到）	2682-2683
頁數	2
期刊	Journal of the American College of Cardiology
卷	72
發行號	21
DOIs	https://doi.org/10.1016/j.jacc.2018.09.032
出版狀態	已發佈 - 11月 27 2018

ASJC Scopus subject areas

@article{ad0dcb88de5849788593f9983b7088d5,

title = "Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted",

author = "Lin, {Yi Cheng} and Chien, {Li Nien} and Huang, {Chun Yao}",

year = "2018",

month = nov,

day = "27",

doi = "10.1016/j.jacc.2018.09.032",

language = "English",

volume = "72",

pages = "2682--2683",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "21",

}

TY - JOUR

T1 - Reply

T2 - Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted

AU - Lin, Yi Cheng

AU - Chien, Li Nien

AU - Huang, Chun Yao

PY - 2018/11/27

Y1 - 2018/11/27

UR - http://www.scopus.com/inward/record.url?scp=85056305729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056305729&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.09.032

DO - 10.1016/j.jacc.2018.09.032

M3 - Letter

C2 - 30466532

AN - SCOPUS:85056305729

SN - 0735-1097

VL - 72

SP - 2682

EP - 2683

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 21

ER -